Judith Abarca‐Zabalía

Genetic predictors of long-term response and trough levels of infliximab in crohn’s disease

Sara Salvador‐Martín, Beatriz López-Cauce, Olga Núñez et al. · Pharmacological Research · 2019 · 39 citations

Life Sciences, Genetics, Immunology +17

Oxidative Status before and after Renal Replacement Therapy: Differences between Conventional High Flux Hemodialysis and on-Line Hemodiafiltration

José Alberto Navarro‐García, Elena Rodríguez‐Sánchez, Jennifer Aceves‐Ripoll et al. · Nutrients · 2019 · 29 citations · Full text

Medicine, Biochemistry, Nephrology +17

New DPYD variants causing DPD deficiency in patients treated with fluoropyrimidine

Xandra García‐González, Bartosz Kaczmarczyk, Judith Abarca‐Zabalía et al. · Cancer Chemotherapy and Pharmacology · 2020 · 22 citations

Life Sciences, Genetics, Molecular Genetics +10

Differential Expression of SMAD Genes and S1PR1 on Circulating CD4+ T Cells in Multiple Sclerosis and Crohn’s Disease

Judith Abarca‐Zabalía, Ma Isabel García, Alberto Lozano Ros et al. · International Journal of Molecular Sciences · 2020 · 20 citations · Full text

Life Sciences, Immunology, Pathobiology +17

Pharmacogenetics of trough serum anti‐TNF levels in paediatric inflammatory bowel disease

Sara Salvador‐Martín, Gemma Pujol‐Muncunill, Ferrán Bossacoma et al. · British Journal of Clinical Pharmacology · 2020 · 19 citations · Full text

Medicine, Genetics, Pharmacology +17